Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 657

1.

[Short version of recommendations for enhanced recovery program (ERP) for cystectomy: Technical measures].

Poinas G, Blache JL, Kassab-Chahmi D, Evrard PL, Artus PM, Alfonsi P, Rébillard X, Beaussier M, Cerantola Y, Coloby P, Drapier É, Houédé N, Masson-Lecomt A, Rouprêt M, Le Normand L, Gamé X, Bosset PO, Delaunay L, Fendler JP, Ecoffey C, Cuvelier G.

Prog Urol. 2019 Jan 8. pii: S1166-7087(18)30681-X. doi: 10.1016/j.purol.2018.12.002. [Epub ahead of print] French.

PMID:
30635149
2.

Bacillus Calmette-Guerin infection following intravesical instillation: Does the strain matter?

Levi LI, Schlemmer F, de Castro N, Brun O, Veziris N, Argemi X, Roupret M, Launay O, Bergeron A, Groh M; BCG infection study group.

Med Mal Infect. 2018 Dec 21. pii: S0399-077X(17)31025-9. doi: 10.1016/j.medmal.2018.11.014. [Epub ahead of print]

PMID:
30583869
3.

Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.

Belhadj Y, Grande P, Seisen T, Gobert A, Gomez FD, Cussenot O, Roupret M.

BJU Int. 2018 Dec 11. doi: 10.1111/bju.14647. [Epub ahead of print]

PMID:
30548115
4.

Role of serum cholinesterase in patients treated with salvage radical prostatectomy.

Vartolomei MD, D'Andrea D, Chade DC, Soria F, Kimura S, Foerster B, Abufaraj M, Mathieu R, Moschini M, Rouprêt M, Briganti A, Karakiewicz PI, Shariat SF.

Urol Oncol. 2019 Feb;37(2):123-129. doi: 10.1016/j.urolonc.2018.11.013. Epub 2018 Dec 3.

PMID:
30522902
5.

Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel.

Soukup V, Čapoun O, Cohen D, Hernández V, Burger M, Compérat E, Gontero P, Lam T, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Yuan Y, Zigeuner R, Babjuk M.

Eur Urol Focus. 2018 Nov 20. pii: S2405-4569(18)30337-7. doi: 10.1016/j.euf.2018.11.005. [Epub ahead of print] Review.

PMID:
30470647
6.

[Update 2018-2020 of French ccAFU guidelines - Editorial].

Méjean A, Bensalah K, Murez T, Rouprêt M, Rozet F.

Prog Urol. 2018 Nov;28(12S):S1-S2. doi: 10.1016/j.purol.2018.10.003. Epub 2018 Nov 20. French. No abstract available.

PMID:
30470340
7.

Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study.

Soria F, Moschini M, D'andrea D, Abufaraj M, Foerster B, Mathiéu R, Gust KM, Gontero P, Simone G, Meraney A, Krishna S, Konety B, Rouprêt M, Perry M, Rowe E, Ploussard G, Boorjian SA, Wiklund P, Sooriakumaran P, Shariat SF.

Eur Urol Focus. 2018 Nov 16. pii: S2405-4569(18)30334-1. doi: 10.1016/j.euf.2018.11.002. [Epub ahead of print]

PMID:
30455153
8.

Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy.

Moschini M, Soria F, Mathieu R, Xylinas E, D'Andrea D, Tan WS, Kelly JD, Simone G, Tuderti G, Meraney A, Krishna S, Konety B, Zamboni S, Baumeister P, Mattei A, Briganti A, Montorsi F, Galucci M, Rink M, Karakiewicz PI, Rouprêt M, Aziz A, Perry M, Rowe E, Koupparis A, Kassouf W, Scherr DS, Ploussard G, Boorjian SA, Sooriakumaran P, Shariat SF; European Association of Urology – Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group.

Urol Oncol. 2018 Nov 13. pii: S1078-1439(18)30395-8. doi: 10.1016/j.urolonc.2018.10.012. [Epub ahead of print]

PMID:
30446442
9.

Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma.

Rieken M, Boorjian SA, Kluth LA, Capitanio U, Briganti A, Thompson RH, Leibovich BC, Krabbe LM, Margulis V, Raman JD, Regelman M, Karakiewicz PI, Rouprêt M, Abufaraj M, Foerster B, Gönen M, Shariat SF.

World J Urol. 2018 Nov 7. doi: 10.1007/s00345-018-2555-5. [Epub ahead of print]

PMID:
30406477
10.

[French ccAFU guidelines - Update 2018-2020: Bladder cancer].

Rouprêt M, Neuzillet Y, Pignot G, Compérat E, Audenet F, Houédé N, Larré S, Masson-Lecomte A, Colin P, Brunelle S, Xylinas E, Roumiguié M, Méjean A.

Prog Urol. 2018 Nov;28(12S):S46-S78. doi: 10.1016/j.purol.2018.07.283. Epub 2018 Oct 23. Review. French.

PMID:
30366708
11.

[French ccAFU guidelines - Update 2018-2020: Upper tract urothelial carcinoma].

Rouprêt M, Xylinas E, Colin P, Houédé N, Compérat E, Audenet F, Larré S, Masson-Lecomte A, Pignot G, Brunelle S, Roumiguié M, Neuzillet Y, Méjean A.

Prog Urol. 2018 Nov;28(12S):S32-S45. doi: 10.1016/j.purol.2018.07.284. Epub 2018 Oct 11. Review. French.

PMID:
30318333
12.

[Venous thromboembolism and urological cancer: Epidemiology and therapeutically management].

Felber M, Rozet F, Droupy S, Misraï V, Smadja DM, Rouprêt M.

Prog Urol. 2019 Jan;29(1):1-11. doi: 10.1016/j.purol.2018.09.002. Epub 2018 Oct 10. French.

PMID:
30316671
13.

Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study Results.

Neuzillet Y, Raynaud JP, Dreyfus JF, Radulescu C, Rouanne M, Schneider M, Krish S, Rouprêt M, Drouin SJ, Comperat E, Galiano M, Cathelineau X, Validire P, Molinié V, Fiet J, Giton F, Lebret T, Botto H.

Horm Cancer. 2019 Feb;10(1):36-44. doi: 10.1007/s12672-018-0351-8. Epub 2018 Oct 6.

PMID:
30293206
14.

[Prognostic value of PD-1/PD-L1 expression in upper tract urothelial carcinoma].

Campedel L, Seisen T, Cussenot O, Comperat E, Varinot J, Rouprêt M, Cancel-Tassin G.

Prog Urol. 2018 Dec;28(16):900-905. doi: 10.1016/j.purol.2018.08.009. Epub 2018 Sep 13. Review. French.

PMID:
30219646
15.

[ypT0N0 after neoadjuvant chemotherapy and cystectomy for muscle-invasive bladder cancer: Incidence and prognosis. A review from the Bladder group of the French Committee of Oncology].

Pignot G, Houédé N, Roumiguié M, Audenet F, Brunelle S, Colin P, Compérat E, Larré S, Masson-Lecomte A, Neuzillet Y, Xylinas E, Méjean A, Rouprêt M; les membres du CCAFU Vessie.

Prog Urol. 2018 Oct;28(12):567-574. doi: 10.1016/j.purol.2018.07.003. Epub 2018 Sep 8. Review. French.

PMID:
30205925
16.

Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patients.

Oderda M, Marra G, Albisinni S, Altobelli E, Baco E, Beatrici V, Cantiani A, Carbone A, Ciccariello M, Descotes JL, Dubreuil-Chambardel M, Eldred-Evans D, Fasolis G, Ferriero M, Fiard G, Forte V, Giacobbe A, Kumar P, Lacetera V, Mozer P, Muto G, Papalia R, Pastore A, Peltier A, Piechaud T, Simone G, Roche JB, Roupret M, Rouviere O, Van Velthoven R, Gontero P.

Int J Urol. 2018 Dec;25(12):990-997. doi: 10.1111/iju.13796. Epub 2018 Sep 5.

PMID:
30187529
17.

Online Professionalism-2018 Update of European Association of Urology (@Uroweb) Recommendations on the Appropriate Use of Social Media.

Borgmann H, Cooperberg M, Murphy D, Loeb S, N'Dow J, Ribal MJ, Woo H, Rouprêt M, Winterbottom A, Wijburg C, Wirth M, Catto J, Kutikov A.

Eur Urol. 2018 Nov;74(5):644-650. doi: 10.1016/j.eururo.2018.08.022. Epub 2018 Sep 1. Review.

PMID:
30177286
18.

Unmet Clinical Needs and Future Perspectives in Non-muscle-invasive Bladder Cancer.

Campi R, Seisen T, Roupret M.

Eur Urol Focus. 2018 Jul;4(4):472-480. doi: 10.1016/j.euf.2018.08.010. Epub 2018 Aug 30. No abstract available.

PMID:
30172757
19.

Immunotherapy for bladder cancer: the fight is on.

Rouprêt M.

World J Urol. 2018 Nov;36(11):1699-1701. doi: 10.1007/s00345-018-2468-3. No abstract available.

PMID:
30167832
20.

Peri-operative and local control outcomes of robot-assisted partial nephrectomy vs percutaneous cryoablation for renal masses: comparison after matching on radiological stage and renal score.

Fraisse G, Colleter L, Peyronnet B, Khene ZE, Mandoorah Q, Soorojebally Y, Bourgi A, De La Taille A, Roupret M, De Kerviler E, Desgrandchamps F, Bensalah K, Masson-Lecomte A.

BJU Int. 2018 Aug 28. doi: 10.1111/bju.14530. [Epub ahead of print]

PMID:
30153399

Supplemental Content

Loading ...
Support Center